FDA Warns Healthcare Professionals to Stop Using Claris IV Bags

The U.S. Food and Drug Administration has alerted healthcare professionals to stop using certain IV bags of metronidazole, ondansetron and ciprofloxacin due to reports of floating matter and possible contamination in IV bags manufactured by Claris Lifesciences Limited, according to an FDA alert.

Advertisement

Potentially affected products are sold under the Claris, Sagent Pharmaceuticals, Pfizer and West-Ward Pharmaceuticals labels, and IV bags sold under the following labels should be removed immediately from pharmacy inventories:

  • Claris — metronidazole, ciprofloxacin, ondansetron
  • Pfizer — metronidazole, ciprofloxacin, ondansetron
  • Sagent Pharmaceuticals — metronidazole, ondansetron
  • West–Ward Pharmaceuticals — metronidazole, ondansetron

Sagent does sell IV bags of ciprofloxacin, but they are not made by Claris and are not subject to this recall, according to the alert.

Read the FDA’s alert on the Claris IV bag contamination.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.